Vergoeding 2019-2023 voor ATC-subgroep L03AB : Interferonen
- Raming voor de totale Zvw-populatie
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
L03AB03 Interferon gamma (Immukine ®) | 505.120 | 488.910 | 494.310 | 510.090 | 416.790 |
L03AB04 Interferon alfa 2a | 102.580 | 6.380 | . | . | . |
L03AB05 Interferon alfa 2b | 3.710 | . | . | . | . |
L03AB07 Interferon beta 1a (Avonex ®) | 14.600.700 | 12.209.000 | 8.898.500 | 7.828.200 | 6.374.000 |
L03AB08 Interferon beta 1b (Betaferon ®) | 2.400.600 | 2.032.900 | 1.394.800 | 1.073.900 | 849.900 |
L03AB11 Peginterferon alfa 2a (Pegasys ®) | 2.320.600 | 2.645.500 | 2.795.800 | 3.867.600 | 4.373.800 |
L03AB13 Peginterferon beta-1a (Plegridy ®) | 5.092.400 | 4.957.300 | 4.445.500 | 3.957.600 | 2.971.100 |
L03AB15 Ropeginterferon alfa-2b (Besremi ®) | . | . | . | 31.535 | 960.090 |
Totaal | 25.025.710 | 22.339.990 | 18.028.910 | 17.268.925 | 15.945.680 |